Kurzporträt
Das Unternehmen hat Niederlassungen in Lille, Paris, Zürich und Cambridge, MA (USA).
Umsatz nach Geschäftsbereich
EUR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Research and Development of Innovative Medicines and Diagnostic Solutions
100,0
%
| 20 | 100,0 % | 29 | 100,0 % | +41.45% |
Umsatz je Region
EUR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
France
100,0
%
| 20 | 100,0 % | 29 | 100,0 % | +41.45% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 56 | 01.05.18 |
Founder | 68 | 01.09.99 | |
Thomas Baetz
DFI | Director of Finance/CFO | 50 | 22.04.21 |
John Brozek
CTO | Chief Tech/Sci/R&D Officer | 47 | - |
Stefanie Magner
CMP | Compliance Officer | 43 | 01.01.16 |
Pascal Caisey
COO | Chief Operating Officer | 56 | 01.09.19 |
Carol L. Addy
CTO | Chief Tech/Sci/R&D Officer | 64 | 09.09.19 |
Meriam Kabbaj
CTO | Chief Tech/Sci/R&D Officer | 50 | 01.12.22 |
Dean Hum
CTO | Chief Tech/Sci/R&D Officer | 61 | 01.01.00 |
Investor Relations Contact | 47 | 01.01.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 67 | 04.03.21 | |
Founder | 68 | 01.09.99 | |
Founder | 52 | 15.09.99 | |
Director/Board Member | 82 | 18.10.06 | |
Catherine Larue
BRD | Director/Board Member | 68 | 16.06.17 |
Director/Board Member | 56 | 16.06.17 | |
Katherine Kalin
BRD | Director/Board Member | 61 | 07.07.20 |
Eric Baclet
BRD | Director/Board Member | 64 | 07.07.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 49 834 983 | 43 240 391 ( 86,77 %) | 0 | 86,77 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+42.41% | 58.71 Mrd. | |
-3.01% | 41.31 Mrd. | |
+36.33% | 39.2 Mrd. | |
-10.22% | 27.4 Mrd. | |
+10.46% | 26.55 Mrd. | |
-22.21% | 18.98 Mrd. | |
+0.85% | 12.51 Mrd. | |
+26.58% | 12.08 Mrd. | |
+21.02% | 11.94 Mrd. |